SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-22-091782
Filing Date
2022-03-31
Accepted
2022-03-31 16:12:05
Documents
9
Period of Report
2022-05-24

Document Format Files

Seq Description Document Type Size
1 DEF 14A d266748ddef14a.htm DEF 14A 442279
2 GRAPHIC g266748g01a01.jpg GRAPHIC 37467
3 GRAPHIC g266748g06a06.jpg GRAPHIC 55920
4 GRAPHIC g266748g13j07.jpg GRAPHIC 17377
5 GRAPHIC g266748g45g54.jpg GRAPHIC 200233
6 GRAPHIC g266748g51w01.jpg GRAPHIC 53138
7 GRAPHIC g266748g65g45.jpg GRAPHIC 107547
8 GRAPHIC g266748g73l41.jpg GRAPHIC 60831
9 GRAPHIC g266748g90t91.jpg GRAPHIC 23079
  Complete submission text file 0001193125-22-091782.txt   1195462
Mailing Address 2970 WILDERNESS PLACE SUITE 100 BOULDER CO 80301
Business Address 2970 WILDERNESS PLACE SUITE 100 BOULDER CO 80301 303-417-0500
BIODESIX INC (Filer) CIK: 0001439725 (see all company filings)

IRS No.: 203986492 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39659 | Film No.: 22792621
SIC: 8071 Services-Medical Laboratories